EGFR and lung adenocarcinoma: Epidermal growth factor receptor (EGFR) mutations are present in 66.3% of Asian non-smokers with lung adenocarcinoma (LUAD) [3], and brain metastasis is detected in up to 29% of these patients at initial diagnosis [4].